Related Experiment Video
Updated: Oct 8, 2025

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Microalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021
Peter Rossing1, Murray Epstein2
1Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Head of Complications Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
Early screening for chronic kidney disease (CKD) is vital, as it often lacks symptoms but has effective interventions. Regular urine albumin and blood creatinine/cystatin C tests can detect CKD and improve patient prognosis.
Area of Science:
- Nephrology
- Public Health
- Cardiology
Background:
- Chronic kidney disease (CKD) impacts 10% of the global population, with diabetes as the primary cause.
- CKD, characterized by impaired kidney function or albuminuria, significantly elevates risks of renal function decline, cardiovascular disease, and mortality.
- Early-stage CKD is often asymptomatic, underscoring the critical need for proactive screening.
Purpose of the Study:
- To emphasize the importance of early screening for chronic kidney disease (CKD).
- To highlight the availability of new interventions that can significantly reduce CKD-associated risks.
- To advocate for the regular screening and management of CKD and its risk factors.
Main Methods:
- Screening involves regular measurement of urinary albumin and blood creatinine or cystatin C to estimate kidney function.
- Current data show albuminuria screening rates are low, ranging from 20% to 50% in at-risk populations.
- Clinicians must integrate regular screening with risk factor management.
Main Results:
- Despite the critical need, albuminuria screening is underutilized, occurring in only 20%-50% of individuals at risk.
- Effective interventions are available to mitigate the severe risks associated with CKD.
- A reduction in albuminuria post-intervention serves as a key indicator of improved prognosis.
Conclusions:
- Regular screening for CKD using albuminuria and kidney function tests is essential for early detection and intervention.
- Implementing recently approved therapeutic options can dramatically reduce the high risks associated with CKD.
- Achieving a reduction in albuminuria is a crucial treatment target, signifying a better patient outlook.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome III : Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Urinary Tract Calculi V: Nursing Management
Nephrotic Syndrome I : Introduction

